September 15, 2022 News by Vanda Pinto, PhD H. Pylori Infection May Increase MS Risk But More Studies Are Needed Infection with the stomach bacterium Helicobacter pylori (H. pylori) does not appear to protect against the development of multiple sclerosis (MS), a review study has found. However, when researchers focused on studies that used microscopic assessments of tissue instead of other diagnostic methods to detect H. pylori, their data…
January 26, 2016 News by Patricia Silva, PhD Amarantus Subsidiary Merging into Avant Diagnostics to Streamline Assets Amarantus Bioscience Holdings, Inc., and Avant Diagnostics recently announced they have entered into a Letter of Intent (LOI) to merge Amarantus Diagnostics, an Amarantus-owned subsidiary, into Avant Diagnostics. The merger is being undertakenĀ to advance the commercial development of diagnostic assets in the fields of oncology and neurology, includingĀ thoseĀ specifically…
January 14, 2016 News by Patricia Silva, PhD Simple MS Blood Test Said to Be Able to Diagnose Disease at Symptom Onset IQuity Labs, which specializesĀ in diagnostic tests for autoimmune and other diseases, recently announced that it has received $2 million in seed funding to support the launch of itsĀ test panels, diagnostic tests designed to confirm the presence or absence of disease at the very onset of symptoms. The first to…
July 30, 2015 News by Maureen Newman MSPrecise Shown to be Accurate in Diagnosing RRMS in Study Cohort A new study testingĀ Amarantus Diagnostics’Ā MSPrecise on multiple sclerosisĀ patients identified the test as a specific and sensitive diagnostic test for multiple sclerosis. The test accurately diagnosed 84% of multiple sclerosis patients from a broad range of subjectsĀ with potential neurological diseases. These results further support Amarantus Diagnostics’ ability to design next generation…
June 25, 2015 News by Maureen Newman Innovative “Nanoprobe” Used to Diagnose Multiple Sclerosis A nanometric sensor — an extremely small probe originally designed to test samples for the presence of herbicides, heavy metals, and pollutants — was experimentally shown to also detect molecules commonly associated with multiple sclerosis. Physicist FĆ”bio de Lima Leite, a professor at the Federal University of SĆ£o Carlos (UFSCar),…
June 25, 2015 News by Patricia Silva, PhD Researchers Offer New Insights into the Link Between Multiple Sclerosis and Specific Autoantibodies Researchers at Immco Diagnostics and the State University of New York in Buffalo recently reported in the journal PLoS One that the frequency of specific auto reactive antibodies does not differ between patients with multiple sclerosis (MS) and people without the disease — a finding…
November 28, 2014 News by Patricia Silva, PhD Diagnostic System by Luoxis Can Detect Oxidative Stress in MS Luoxis Diagnostics, Inc. recently presented three clinical and preclinical findings that feature the company’s proprietaryĀ RedoxSYSā¢ Diagnostic System as a comprehensive, groundbreaking tool for research capable of assessing a patient’sĀ oxidation-reduction potential (ORP) in the event ofĀ injury, illness, or stress.Ā The findings were presented as peer-reviewed posters during the recently concludedĀ …